# Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis

Review · Mark H. Ebell, Henry C Barry, Kanishka Baduni, Gabrielle Grasso

- Archive id: doi:10.1370/afm.3050
- Published: 2024-01-01
- Venue: The Annals of Family Medicine
- DOI: https://doi.org/10.1370/afm.3050
- PMID: 38253509
- Citations: 100
- Source URL: https://doi.org/10.1370/afm.3050
- PDF: https://www.annfammed.org/content/annalsfm/22/1/50.full.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.